Autori: Herbst Roy S
| Naslov | Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC (Article) |
| Autori | Herbst Roy S ... Andric Zoran G  ... (broj koautora 22)
|
| Info | NEW ENGLAND JOURNAL OF MEDICINE, (2020), vol. 383 br. 14, str. 1328-1339 |
| Projekat | Roche HoldingGenentech; IMpower110 ClinicalTrials.gov number [NCT02409342] |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
     |
